StockComparison Logo
vs

NSRX vs SKYE

Comparison between Nasus Pharma Ltd (NSRX, Company) and Skye Bioscience Inc (SKYE, Company).

Both NSRX and SKYE are from the Healthcare sector.

NSRX vs SKYE - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
NSRX
$27M
Winner
SKYE
$27M
Max Drawdown
Winner
NSRX
78.03%
SKYE
99.96%
Sharpe Ratio
NSRX
-0.57
Winner
SKYE
-0.30
5Y Beta
Winner
NSRX
0.86
SKYE
1.48
Industry
NSRX
Drug Manufacturers - General
SKYE
Biotechnology
P/E Ratio
Winner
NSRX
-4.66
SKYE
-0.44
PEG Ratio
Winner
NSRX
-0.02
SKYE
-0.01
5Y EPS CAGR
NSRX
N/A
SKYE
-21.69%
Debt to Equity
NSRX
0.00%
SKYE
0.00%
Free Cash Flow Yield
NSRX
-18.05%
SKYE
N/A
P/S Ratio
NSRX
N/A
SKYE
117.90
P/B Ratio
NSRX
12.82
Winner
SKYE
3.04

NSRX vs SKYE - Historical Returns

Returns include dividend reinvestment.

1M
NSRX
-3.84%
Winner
SKYE
-3.23%
3M
NSRX
-37.66%
Winner
SKYE
+11.34%
6M
NSRX
-57.65%
Winner
SKYE
-27.78%
1Y
NSRX
-65.09%
Winner
SKYE
-63.72%
5Y(CAGR)
NSRX
N/A
SKYE
-54.40%
10Y(CAGR)
NSRX
N/A
SKYE
-39.77%
Max(CAGR)
NSRX
-71.88%
Winner
SKYE
-48.37%

NSRX vs SKYE - Annual Returns (2015 - 2026)

Returns include dividend reinvestment.

YearNSRXSKYE
2026-61.85%-10.36%
2025+10.91%-73.69%
2024N/A+4.04%
2023N/A-34.85%
2022N/A-70.55%
2021N/A+29.68%
2020N/A-72.41%
2019N/A-65.53%
2018N/A+116.22%
2017N/A-56.57%
2016N/A-52.81%
2015N/A-86.41%

NSRX vs SKYE Drawdown Comparison

The maximum drawdown for NSRX was -78.03%, occurring on Mar 30, 2026. This drawdown has not yet recovered.

The maximum drawdown for SKYE was -99.96%, occurring on Mar 27, 2026. This drawdown has not yet recovered.

The current NSRX drawdown is -68.52%. The current SKYE drawdown is -99.94%.

RankNSRXSKYE
#1-78.03%
Dec 31, 2025 - Mar 30, 2026
-99.96%
Apr 7, 2015 - Mar 27, 2026
#2-30.96%
Aug 19, 2025 - Dec 31, 2025
N/A
#3-2.42%
Aug 13, 2025 - Aug 18, 2025
N/A

Correlation

Correlation between NSRX and SKYE is 0.48 which considered as a weak positive correlation - the stocks show a slight tendency to move together.

0.48
-101

Select Stocks to Compare